Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Abstract
CONTEXT: The polycystic ovary syndrome (PCOS) is the most common endocrine abnormality of reproductive-aged women today, affecting approximately 6.6% of unselected reproductive-aged women (approximately 4 million women in the United States) (1990 National Institutes of Health criteria), and potentially represents a significant financial burden to our health care. OBJECTIVE: The objective of the study was to define, using current definitions and prevalence or incidence data, the minimal economic burden that PCOS in reproductive-aged women represents for the United States. DESIGN: The study design was a literature review. SETTING: The study was conducted at a tertiary care center. PATIENTS OR OTHER PARTICIPANTS: There were no patients or other participants. INTERVENTION(S): We performed a systematic review of the published medical literature to identify studies evaluating epidemiology of reproductive-age PCOS and its clinical consequences and costs. We tied general societal cost data for the different health consequences to reproductive-age PCOS costs, using prevalence data. MAIN OUTCOME MEASURE(S): The main measure in the study was total health care-related economic costs. RESULTS: We estimated the mean annual cost of the initial evaluation to be dollar 93 million (2.1% of total costs), that of hormonally treating menstrual dysfunction/abnormal uterine bleeding to be dollar 1.35 billion (31.0% of total), that of providing infertility care to be dollar 533 million (12.2% of total), that of PCOS-associated diabetes to be dollar 1.77 billion (40.5% of total), and that of treating hirsutism to be dollar 622 million (14.2% of total). CONCLUSIONS: The total cost of evaluating and providing care to reproductive-aged PCOS women in the United States is dollar 4.36 billion. Because the cost of the diagnostic evaluation accounted for a relatively minor part of the total costs (approximately 2%), more widespread and liberal screening for the disorder appears be a cost-effective strategy, leading to earlier diagnosis and intervention and possibly the amelioration and prevention of serious sequelae.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“comprehensive screening and counseling from physicians and greater public awareness can curtail morbidity and reduce the economic burden on both the patient and the healthcare system.”
From 'I'm usually being my own doctor': women's experiences of managing polycystic ovary syndrome in Canada (2023) · cites this paper as [61]
In the citing paper
“PCOS has a high healthcare-related economic burden”
From 'I'm usually being my own doctor': women's experiences of managing polycystic ovary syndrome in Canada (2023) · cites this paper as [61]
In the citing paper
“Also from a resource allocation perspective, the financial costs related to diagnosis of PCOS are only a small fraction (2%) of the total costs associated with comprehensive care for PCOS in the United States (32).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [32]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Self-citationMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Self-citationAsunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Self-citationDiamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4006 · Cited by 1,110
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients
Balen, A. H., Conway, G. S., Kaltsas, G., Techatraisak, K., Manning, P. J., West, C., & Jacobs, H. S. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136243 · Cited by 1,060
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-83 · Cited by 815
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., & Odén, A. (1992) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016349209006227 · Cited by 548
Menstrual cycle irregularity and risk for future cardiovascular disease
Solomon, C. G., Hu, F. B., Dunaif, A., Rich-Edwards, J. E., Stampfer, M. J., Willett, W. C., Speizer, F. E., & Manson, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8471 · Cited by 528
Azziz, R., Ehrmann, D., Legro, R. S., Whitcomb, R. W., Hanley, R., Fereshetian, A. G., O’Keefe, M., & Ghazzi, M. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7375 · Cited by 517
Self-citationMortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504
Effects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome
Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., Roberts, K. A., & Nestler, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8207 · Cited by 492
Economic Costs of Diabetes in the U.S. in 2002Preprint
Dall, T. M., Nikolov, P., & Hogan, P. F. (2003) · RePEc: Research Papers in Economics · Cited by 482
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466
Hypersecretion of luteinising hormone, infertility, and miscarriage
Regan, L., Owen, E. J., & Jacobs, H. S. (1990) · The Lancet · doi:10.1016/0140-6736(90)92765-a · Cited by 450
CONWAY, G. S., HONOUR, J. W., & JACOBS, H. S. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00446.x · Cited by 445
Carmina, E., Koyama, T., Chang, L., Stanczyk, F. Z., & Lobo, R. A. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91779-a · Cited by 444
Polycystic ovaries and associated clinical and biochemical features in young women
Michelmore, K. F., Balen, A. H., Dunger, D. B., & Vessey, M. P. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00886.x · Cited by 439
Homburg, R., Armar, N. A., Eshel, A., Adams, J., & Jacobs, H. S. (1988) · BMJ · doi:10.1136/bmj.297.6655.1024 · Cited by 436
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus
Ovalle, F., & Azziz, R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03111-4 · Cited by 428
Self-citationPolycystic ovary syndrome and endometrial carcinoma
Hardiman, P., Pillay, O. S., & Atiomo, W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13409-5 · Cited by 414
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
Solomon, C. G. (2001) · JAMA · doi:10.1001/jama.286.19.2421 · Cited by 362
The Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.36 · Cited by 358
Wijeyaratne, C. N., Balen, A. H., Barth, J. H., & Belchetz, P. E. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01603.x · Cited by 314
The burden of hepatitis C in the United States
Kim, R. W. (2002) · Hepatology · doi:10.1002/hep.1840360705 · Cited by 299
Tarkun, İ., Arslan, B. Ç., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 296
Wallach, E. E., & Goldzieher, J. W. (1981) · Fertility and Sterility · doi:10.1016/s0015-0282(16)45429-4 · Cited by 296
Recurrent early miscarriage and polycystic ovaries.
Sagle, M., Bishop, K., Ridley, N., Alexander, F. M., Michel, M., Bonney, R. C., Beard, R. W., & Franks, S. (1988) · BMJ · doi:10.1136/bmj.297.6655.1027 · Cited by 283
Clinical and Biochemical Features of Polycystic Ovarian Disease
Goldzieher, J. W., & Axelrod, L. R. (1963) · Fertility and Sterility · doi:10.1016/s0015-0282(16)35047-6 · Cited by 283
Orio, F., Palomba, S., Spinelli, L., Cascella, T., Tauchmanovà, L., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032049 · Cited by 275
Talbott, E. O., Zborowski, J. V., Rager, J. R., Boudreaux, M. Y., Edmundowicz, D. A., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032237 · Cited by 273
Impact of morbid obesity on medical expenditures in adults
Arterburn, D. E., Maciejewski, M. L., & Tsevat, J. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802896 · Cited by 269
Balen, A. H., Tan, S.-L., MacDougall, J., & Jacobs, H. S. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138174 · Cited by 258
Elting, M. W., Korsen, T. J. M., Bezemer, P. D., & Schoemaker, J. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.556 · Cited by 254
Work loss associated with increased menstrual loss in the United States
Côté, I. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02094-x · Cited by 247
Azziz, R., Hincapie, L. A., Knochenhauer, E. S., Dewailly, D., Fox, L., & Boots, L. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00383-0 · Cited by 244
Self-citationPolycystic ovary syndrome and cancer
Balen, A. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.6.522 · Cited by 218
Obstetric outcome in women with polycystic ovarian syndrome
Mikola, M. (2001) · Human Reproduction · doi:10.1093/humrep/16.2.226 · Cited by 206
Ehrmann, D. A., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0229 · Cited by 205
Self-citationJackson, R. L., & Dockerty, M. B. (1957) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)37277-5 · Cited by 200
Quality of life of hirsute women
Sonino, N., Fava, G. A., Mani, E., Belluardo, P., & Boscaro, M. (1993) · Postgraduate Medical Journal · doi:10.1136/pgmj.69.809.186 · Cited by 193
The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia
Futterweit, W., Dunaif, A., Yeh, H.-C., & Kingsley, P. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70241-8 · Cited by 189
Nestler, J. (1997) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-1016294 · Cited by 184
Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome
Winters, S. J., Talbott, E., Guzick, D. S., Zborowski, J., & McHugh, K. P. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00641-x · Cited by 182
Guyatt, G. H., Weaver, B., Cronin, L., Dooley, J. A., & Azziz, R. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.10.018 · Cited by 170
Self-citationO'Driscoll, J. B., Mamtora, H., Higginson, J., Pollock, A., Kane, J., & Anderson, D. C. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02535.x · Cited by 152
Bjercke, S., Dale, P. O., Tanbo, T., Storeng, R., Ertzeid, G., & Åbyholm, T. (2002) · Gynecologic and Obstetric Investigation · doi:10.1159/000067719 · Cited by 138
Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama
Azziz, R., Waggoner, W., Ochoa, T., Knochenhauer, E. S., & Boots, L. R. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00141-1 · Cited by 133
Self-citationKarande, V. C., Korn, A., Morris, R. S., Rao, R., Balin, M., Rinehart, J., Dohn, K., & Gleicher, N. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00490-7 · Cited by 128
Cardiovascular Risk In Women With Polycystic Ovary Syndrome
Talbott, E. O., Zborowski, J. V., Sutton-Tyrrell, K., McHugh-Pemu, K. P., & Guzick, D. S. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70189-3 · Cited by 126
Impaired glucose tolerance in pregnant women with polycystic ovary syndrome
Radon, P. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00252-5 · Cited by 123
Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome
Cheung, A. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01432-6 · Cited by 121
The Economic Cost of Diabetes in Canada, 1998
Dawson, K. G., Gomes, D. R. J., Gerstein, H. C., Blanchard, J., & Kahler, K. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1303 · Cited by 119
Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome
Glueck, C. J., Bornovali, S., Pranikoff, J., Goldenberg, N., Dharashivkar, S., & Wang, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01251.x · Cited by 115
ENDOMETRIAL HYPERPLASIA IN YOUNG WOMEN
Chamlian, D. L., & Taylor, H. B. (1971) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197105000-00019 · Cited by 113
Critchley, H., Warner, P., Lee, A., Brechin, S., Guise, J., & Graham, B. (2004) · Health Technology Assessment · doi:10.3310/hta8340 · Cited by 110
The impact of ethnicity on the presentation of polycystic ovarian syndrome
Williamson, K., Gunn, A. J., JOHNSON, N. P., & Milsom, S. R. (2001) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2001.tb01210.x · Cited by 110
Prevalence of polycystic ovaries in women with androgenic alopecia
Cela, E., Robertson, C., Rush, K., Κousta, E., White, D. M., Wilson, H., Lyons, G., Kingsley, P., McCarthy, M. I., & Franks, S. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490439 · Cited by 110
The Genetics of Obesity Lessons for Polycystic Ovary Syndrome
LEGRO, R. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06230.x · Cited by 109
Costs of Occupational Injuries in Agriculture
Leigh, J. P., McCurdy, S. A., & Schenker, M. B. (2001) · Public Health Reports · doi:10.1093/phr/116.3.235 · Cited by 108
Higher risk of preeclampsia in the polycystic ovary syndrome
de Vries, M. J., Dekker, G., & Schoemaker, J. (1998) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(97)00164-4 · Cited by 106
Prevalence of idiopathic hirsutism
Carmina, E. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390421 · Cited by 105
Regulation of Sex Hormone Binding Globulin (SHBG) production in hep G2 cells by insulin
Plymate, S. R., Jones, R. E., Matej, L. A., & Friedl, K. E. (1988) · Steroids · doi:10.1016/0039-128x(88)90136-5 · Cited by 99
Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage
Watson, H., Kiddy, D. S., Hamilton-Fairley, D., Scanlon, M. J., Barnard, C., Collins, W. P., Bonney, R. C., & Franks, S. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138149 · Cited by 96
The economic impact of the assisted reproductive technologies
Katz, P., Nachtigall, R. D., & Showstack, J. A. (2002) · Nature Cell Biology · doi:10.1038/ncb-nm-fertilitys29 · Cited by 89
Hara, M., Alcoser, S. Y., Qaadir, A., Beiswenger, K. K., Cox, N. J., & Ehrmann, D. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8255 · Cited by 89
FridstrÖM, M., Nisell, H., SjÖBlom, P., & Hillensjo, T. (1999) · Hypertension in Pregnancy · doi:10.3109/10641959909009612 · Cited by 71
Laser hair reduction in the hirsute patient: a critical assessment
Sanchez, L. A. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.2.169 · Cited by 71
Farah, L. A., Lazenby, A. J., Boots, L. R., & Azziz, R. (1999) · PubMed · Cited by 65
Self-citationHigh incidence of preeclamptic toxemia in patients with polycystic ovarian disease
Diamant, Y. Z., Rimon, E., & Evron, S. (1982) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(82)90097-1 · Cited by 64
Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome.
Wortsman, J., Ángeles, S. D. L., Futterweit, W., Singh, K. B., & Kaufmann, R. C. (1991) · PubMed · Cited by 50
Polycystic ovary disease and the risk of pregnancy-induced hypertension.
Kashyap, S., & Claman, P. (2000) · PubMed · Cited by 47
Piltonen, T., Koivunen, R., Perheentupa, A., Morin-Papunen, L., Ruokonen, A., & Tapanainen, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031851 · Cited by 42
The time has come to simplify the evaluation of the hirsute patient
Azziz, R. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01526-0 · Cited by 32
Self-citationOvulation Failure and Induction
Hull, M. G. R. (1981) · Clinics in Obstetrics and Gynaecology · doi:10.1016/s0306-3356(21)00177-1 · Cited by 24
Braunstein, J. B. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00738-5 · Cited by 20
Cardiovascular Health in Women with Polycystic Ovary Syndrome
Sukalich, S., & Guzick, D. S. (2003) · Seminars in Reproductive Medicine · doi:10.1055/s-2003-43309 · Cited by 19
Ciampelli, M., Fulghesu, A. M., & Lanzone, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5939-3 · Cited by 11
A one-year experience with a capitated health care plan for infertility
Blackwell, R. E., Hammond, K. R., & Steinkampf, M. P. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01673-9 · Cited by 6
Dumesic, D. A., Rr, H., & O'Brien, A. M. (1997) · PubMed · Cited by 4
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
“4 billion in the United States alone (68).”
BackgroundAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
“dometrial carcinoma, obesity, type 2 diabetes mellitus, dyslipidemia, hypertension, and possibly cardiovascular disease (5).”
BackgroundSelf-citationAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
“PCOS has also been noted to affect 28% of unselected obese and 5% of lean women [5-8].”
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Metadata
- Authors
- Azziz, R., Marin, C., Hoq, L., Badamgarav, E., & Song, P.
- Affiliations
- Cedars-Sinai Medical Center (US)
- ORCID
- Azziz, Ricardo
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-08
- Volume
- 90
- Issue
- 8
- Pages
- 4650-4658
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2118575626
- Cited by
- 537
- References
- 90
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 29 · 2023: 28 · 2022: 36 · 2021: 45 · 2020: 25 · 2019: 41 · 2018: 27 · 2017: 27 · 2016: 22 · 2015: 20 · 2014: 27 · 2013: 24 · 2012: 26
- FWCI
- 18.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (K24-D01346)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD029364, R01-HD29364)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- polycystic ovary syndrome, economic burden, health care costs, women of reproductive age, infertility treatment, hirsutism, abnormal uterine bleeding, menstrual disorders, PCOS screening, cost estimation
- MeSH terms
- Adolescent, Adult, Female, Humans, Polycystic Ovary Syndrome, United States, Incidence, Prevalence, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.